Publications by authors named "Anthony Markham"

Claim this Profile
C
Correction to: Daridorexant: First Approval.
Anthony Markham

Drugs· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daridorexant: First Approval.
Anthony Markham

Drugs· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefapixant: First Approval.
Anthony Markham

Drugs· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell Carcinoma.
Anthony Markham

Target Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Envafolimab: First Approval.
Anthony Markham

Drugs· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisotumab Vedotin: First Approval.
Anthony Markham

Drugs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Avatrombopag: A Review in Thrombocytopenia.
Anthony Markham

Drugs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avatrombopag: A Review in Thrombocytopenia.
Anthony Markham

Drugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zimberelimab: First Approval.
Anthony Markham

Drugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobocertinib: First Approval.
Anthony Markham

Drugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Savolitinib: First Approval.
Anthony Markham

Drugs· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dostarlimab: First Approval.
Anthony Markham

Drugs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pamiparib: First Approval.
Anthony Markham

Drugs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ponesimod: First Approval.
Anthony Markham

Drugs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evinacumab: First Approval.
Anthony Markham

Drugs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Margetuximab: First Approval.
Anthony Markham

Drugs· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vericiguat: First Approval.
Anthony Markham, Sean Duggan

Drugs· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirbanibulin: First Approval.
Anthony Markham, Sean Duggan

Drugs· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naxitamab: First Approval.
Anthony Markham

Drugs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setmelanotide: First Approval.
Anthony Markham

Drugs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Selpercatinib: First Approval.
Anthony Markham

Drugs· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enarodustat: First Approval.
Anthony Markham

Drugs· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGN-EB3: First Approval.
Anthony Markham

Drugs· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Oliceridine: First Approval.
Anthony Markham

Drugs· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralsetinib: First Approval.
Anthony Markham

Drugs· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis